Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Dianthus Therapeutics, Inc. DNTH

Set alert

Price alert · DNTH

All alert types
84.39 USD +2.14 +2.60%

As of Nov 3, 10:07 AM ET

Bid
84.44 × 1
Ask
84.70 × 1
82.24 Day range 84.79
32.42 52-week range 117.88
YTD
+104.78%
1 year
+147.99%
Open
83.21
Prev close
82.25
Mkt cap
4.61B
Vol
36.71K
Avg vol
813.26K
EPS
-4.23
P/E
0.00
Div yield
0.00%
More statistics
Low
82.24
High
84.79
Forward P/E
-17.84
Beta
0.26
Short ratio
9.16
Inst. own
129.89%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
92.76
200-d avg
85.03
1y target
139.06

1M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 27, 2026Rating: Roth Capital · — → Buy
Signals (2)
NameDateAgo
MACD: Buy SignalOct 21, 20261 week ago
SMA: BullishOct 20, 20262 weeks ago

Financial health

Altman Z-Score

67.20 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 5
  • P/E 1
  • P/B 2

Valuation

P/E -9.8×
FY 2016: -54.4×FY 2017: -14.5×FY 2018: -3.3×FY 2019: -7.3×FY 2020: -4.6×FY 2021: -18.6×FY 2022: -0.8×FY 2023: -1.2×FY 2024: -8.5×FY 2025: -9.8×
FY 2016 5y median -8.5× FY 2025
P/S 765×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 165×FY 2022: 3.7×FY 2023: 19.0×FY 2024: 116×FY 2025: 765×
FY 2016 5y median 116× FY 2025
P/B 3.2×
FY 2016: 56.8×FY 2017: 10.2×FY 2018: 1.3×FY 2019: 4.0×FY 2020: 2.4×FY 2021: 1.4×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 2.1×FY 2025: 3.2×
FY 2016 5y median 1.4× FY 2025
P/FCF -12.0×
FY 2016: -77.0×FY 2017: -21.0×FY 2018: -3.8×FY 2019: -9.3×FY 2020: -5.3×FY 2021: -4.0×FY 2022: -0.8×FY 2023: -1.4×FY 2024: -9.3×FY 2025: -12.0×
FY 2016 5y median -4.0× FY 2025
EV/EBITDA -9.3×
FY 2016: -55.0×FY 2017: -13.2×FY 2018: -2.3×FY 2019: -6.6×FY 2020: -3.9×FY 2021: -10.1×FY 2022: -0.3×FY 2023: 1.8×FY 2024: -8.3×FY 2025: -9.3×
FY 2016 5y median -8.3× FY 2025
EV/Sales 741×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 75.7×FY 2022: 1.4×FY 2023: -27.7×FY 2024: 113×FY 2025: 741×
FY 2016 5y median 75.7× FY 2025
FCF Yield -8.3%
FY 2016: -1.3%FY 2017: -4.8%FY 2018: -26.1%FY 2019: -10.7%FY 2020: -18.7%FY 2021: -25.0%FY 2022: -123.3%FY 2023: -69.0%FY 2024: -10.8%FY 2025: -8.3%
FY 2016 5y median -25.0% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -8739.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -886.6%FY 2022: -462.9%FY 2023: -1704.7%FY 2024: -1633.7%FY 2025: -8739.3%
FY 2016 5y median -1633.7% FY 2025
Net Margin -7973.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -888.1%FY 2022: -443.8%FY 2023: -1541.2%FY 2024: -1362.8%FY 2025: -7973.3%
FY 2016 5y median -1362.8% FY 2025
ROE -32.9%
FY 2016: -104.3%FY 2017: -70.5%FY 2018: -39.5%FY 2019: -54.4%FY 2020: -52.1%FY 2021: -7.6%FY 2022: -38.7%FY 2023: -25.8%FY 2024: -24.1%FY 2025: -32.9%
FY 2016 5y median -25.8% FY 2025
ROIC -35.5%
FY 2016: -102.5%FY 2017: -71.0%FY 2018: -40.8%FY 2019: -56.3%FY 2020: -52.4%FY 2021: -7.3%FY 2022: -39.5%FY 2023: -28.3%FY 2024: -28.6%FY 2025: -35.5%
FY 2016 5y median -28.6% FY 2025
ROA -30.6%
FY 2016: -83.2%FY 2017: -65.2%FY 2018: -36.6%FY 2019: -47.5%FY 2020: -46.4%FY 2021: -6.9%FY 2022: -34.3%FY 2023: -24.3%FY 2024: -22.7%FY 2025: -30.6%
FY 2016 5y median -24.3% FY 2025

Growth (YoY)

Revenue -67.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 334.8%FY 2023: -56.0%FY 2024: 120.6%FY 2025: -67.3%
FY 2016 FY 2025
Operating Income -74.7%
FY 2016: 0.0%FY 2017: -285.5%FY 2018: -67.8%FY 2019: -38.4%FY 2020: 5.1%FY 2021: 83.4%FY 2022: -127.0%FY 2023: -62.2%FY 2024: -111.5%FY 2025: -74.7%
FY 2016 FY 2025
EPS (diluted) -64.7%
FY 2016: 0.0%FY 2017: -275.9%FY 2018: -72.1%FY 2019: -20.1%FY 2020: 17.7%FY 2021: 86.0%FY 2022: -99.0%FY 2023: -11.2%FY 2024: 69.8%FY 2025: -64.7%
FY 2016 FY 2025
Free Cash Flow -65.1%
FY 2016: 0.0%FY 2017: -266.9%FY 2018: -102.6%FY 2019: -21.4%FY 2020: -7.1%FY 2021: 5.6%FY 2022: 52.0%FY 2023: -26.6%FY 2024: -111.7%FY 2025: -65.1%
FY 2016 FY 2025

Financial Health

Current Ratio 13.3×
FY 2016: 4.7×FY 2017: 12.7×FY 2018: 13.9×FY 2019: 10.6×FY 2020: 13.3×FY 2021: 16.6×FY 2022: 10.0×FY 2023: 18.4×FY 2024: 15.2×FY 2025: 13.3×
FY 2016 5y median 15.2× FY 2025
Quick Ratio 13.3×
FY 2016: 4.7×FY 2017: 12.7×FY 2018: 13.9×FY 2019: 10.6×FY 2020: 13.3×FY 2021: 16.6×FY 2022: 10.0×FY 2023: 18.4×FY 2024: 15.2×FY 2025: 13.3×
FY 2016 5y median 15.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 0.5×FY 2017: 1.5×FY 2018: 1.0×FY 2019: 0.9×FY 2020: 0.8×FY 2021: 11.9×FY 2022: 0.5×FY 2023: 3.0×FY 2024: 0.3×FY 2025: 0.3×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: -56.9×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -20.9×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31